BioSpace · 3 days ago
Principal Scientist - Translational Immunology
Wonder how qualified you are to the job?
BiotechnologyCommunities
Insider Connection @BioSpace
Responsibilities
The candidate should be able to independently initiate and drive projects, intellectually supervise junior lab members.
Contribute to the project development as well as perform cellular immunological techniques, including multi-color flow cytometry, ELISA, MSD and in vitro immune cell assays.
The candidate with experience in human 3D culture system is strongly preferred.
The candidate is expected to have extensive immunology training and strong cellular immunology and cell culture technical skills.
In addition, the candidate should have strong verbal and written communication skills, be highly motivated, creative and collaborative.
The candidate should have a track record of independent critical thinking and scientific achievement in the area of immunology.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Doctorate degree PhD, PharmD or MD and 2 years of immunology experience
Or Masters degree and 5 years of Immunology experience
Or Bachelors degree and 7 years of Immunology experience
Preferred
Candidates with immuno-toxicology experience
Benefits
Comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
A discretionary annual bonus program
Stock-based long-term incentives
Award-winning time-off plans and bi-annual company-wide shutdowns
Flexible work models, including remote work arrangements, where possible
Company
BioSpace
BioSpace is the leading online community for industry news and careers for life science professionals.
Funding
Current Stage
Growth StageTotal Funding
$10M2000-08-24Series B· $10M
Recent News
2024-05-31
2024-05-05
2024-04-06
Company data provided by crunchbase